Navigation Links
Gene 'knockout' floors tobacco carcinogen
Date:3/18/2008

In large-scale field trials, scientists from North Carolina State University have shown that silencing a specific gene in burley tobacco plants significantly reduces harmful carcinogens in cured tobacco leaves.

The finding could lead to tobacco products especially smokeless products with reduced amounts of cancer-causing agents.

NC State's Dr. Ralph Dewey, professor of crop science, and Dr. Ramsey Lewis, assistant professor of crop science, teamed with colleagues from the University of Kentucky to knock out a gene known to turn nicotine into nornicotine. Nornicotine is a precursor to the carcinogen N-nitrosonornicotine (NNN). Varying percentages of nicotine are turned into nornicotine while the plant ages; nornicotine converts to NNN as the tobacco is cured, processed and stored.

The field tests in Kentucky, Virginia and North Carolina compared cured burley tobacco plants with the troublesome gene silenced and "control" plant lines with normal levels of gene expression. The researchers found a six-fold decrease in carcinogenic NNN in the genetically modified tobacco plants, as well as a 50 percent overall reduction in the class of harmful compounds called TSNAs, or tobacco-specific nitrosamines. TSNAs are reported to be among the most important tobacco-related compounds implicated in various cancers in laboratory experiments, Lewis said.

The research results were published online in Plant Biotechnology Journal.

Lewis and Dewey stress that the best way for people to avoid the risks associated with tobacco use is to avoid using tobacco products. But their findings show that targeted gene silencing can work as well in the field as it does on the lab bench.

"Creating a tobacco plant with fewer or no harmful compounds may also help with tobacco plants that are being used to create pharmaceuticals or other high-value products," Dewey said.

To get initial lines of plants with the troublesome gene silen
'/>"/>

Contact: Dr. Ralph Dewey
ralph_dewey@ncsu.edu
919-515-2705
North Carolina State University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pitt study finds inequality in tobacco advertising
2. Tennessee Faith Leaders Call on Reps. Gordon & Blackburn to Co-sponsor Legislation to Protect Kids from Tobacco
3. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
4. President Bush Should Protect Kids, Not Big Tobacco By Signing Bill to Increase Cigarette Tax, Fund SCHIP
5. Tobacco-Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking
6. Congressional Support Grows for FDA Regulation of Tobacco: Bill Now Sponsored by 55 Senators, 200 Representatives
7. Congress Starts Hearings on FDAs Control of Tobacco
8. Presidents Veto of Bill to Increase Cigarette Tax, Fund SCHIP Benefits Big Tobacco at Expense of Americas Kids
9. UGA study: Youth exposed to smokeless tobacco ads despite settlement
10. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
11. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... NORWALK, Conn., July 24 /PRNewswire/ -- People t... cruises offer many opportunities to eat right,and...e excellent menu,selections, so if you order caref...u., (Photo: http://www.newscom.com/cgi-bin/prnh/... handle temptation, you,ll want to stay,away from ...
(Date:7/24/2008)... The Palomino Group, a lead...rganization, today announced the launch of its new...o the biopharmaceutical industry. The company, bas...sement and commercialization consulting services t... device, and other healthcare companies. , ...
(Date:7/23/2008)... Press Ganey reports need for better physician-adm...ces of nearly 28,000 physicians, SOUTH BEND, Ind....2008,Hospital Check-Up Report: Physician Perspecti...es to be a gap in the physician-administration,rel...strators to be more,responsive to the ideas and ne...
(Date:7/23/2008)... NASDAQ: CRME, TSX: COM, VANCOUVER, July 23 /PR...Q: CRME/TSX: COM) today announced that it has ente...s, LLC, an investment fund managed by,CR Intrinsic...visors, LLC,to purchase Series A convertible prefe...roceeds of the financing will be used for general ...
Breaking Medicine News(10 mins):Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 3Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 2Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 3Health News:Authoritative Report on Physician Perspectives Released Today 2Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3
...ndia has declined over the century from 972 in 190... to 933 in 2001. In contrast, the child sex rati...rls per thousand boys against 945 recorded in 1991...tio is concerned, it is 1.01 male (s)/females as i...
...ntessentially Indian puff, has become a victim of ...outhern districts of Tamil Nadu going on strike. ...wrapped in leaf, from Tirunelveli, Tuticorin and K...this weekend to protest the union health ministry ...
...Democratic Front (LDF) government, set to mark its...at it is to blame for the deaths of 38 newborns in...fection in the labour room of the Sree Avittam Tir...the last two months. A court has charged Health M...
...is of concern as it is a reflection of the prevale...s and the extent of transmission of TB infection ...orted under the programme are of paediatric age gr...ntage of paediatric cases reported at national lev...
Other Medicine News:Health News:Bidi Workers Protest Against Using Skull and Crossbones Sign on Packets 2
(Date:7/22/2008)...y and Efficacy of Treating Patients with ...CO, and YONGIN-SI, South Korea, July 22 /PRNewswir..., Ontario), and its South,Korean partner Green Cro...,a Phase I clinical trial of its first-in-class le...s well-tolerated and resulted in clear,anti-cancer...
(Date:7/22/2008)...(R) and Apidra(R) Resulted in Significant, Reducti...ver the Algorithm ... Results from the "Adjust to,Target in Type 2 Diab...rate,Counting for Adjustment of Mealtime Insulin G...abetes Association,s (ADA) medical journal,Diabet...
(Date:7/22/2008)... July 22 /- Hyperion,Therapeutics, In...nrollment,in its Phase 1/2 clinical trial to evalu...g effects of HPN-100 (formally called GT4P) versus...ith urea cycle disorders,(UCD). The company plans ...,of this year., (Logo: http://www.newscom.com/cg...
(Date:7/22/2008)...Columbia University Medical Center Based on ...ogy, The Test Differentiates Squamous From Non-S...ifying Squamous-Cell Carcinoma of the Lung With ...90 Percent,This is the First CLIA Approved Test Wh...iomarkers for Accurate Diagnosis of Lung Cancer, ...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 1NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 2NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 3Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference 3809 1Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference 3809 2More than Seventy Percent of Top US Hospitals Control Patient Temperature with High Tech Arctic Sun 28TM 29 13849 1More than Seventy Percent of Top US Hospitals Control Patient Temperature with High Tech Arctic Sun 28TM 29 13849 2AVMA 3A Keep Pets Safe This Easter 13847 1AVMA 3A Keep Pets Safe This Easter 13847 2
...w Dissociation from HCV,Protease , ,WASHINGTON, Ma...etwork/ -- InterMune, Inc. (Nasdaq: ITMN) today pr...titis C virus (HCV) NS3/4A,protease inhibitor, ITM...e Disease Week (DDW) meeting being held May 19-24 ...ct #M1816) examined,ITMN-191 potency and binding k...
... FDA for long-term maintenance,treatment of COPD b...ed formoterol fumarate provides improved lung func... patient quality of,life, and positive safety prof... Data presented at the,International Conference of...hat Perforomist (formoterol fumarate) Inhalation,S...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 4InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum.
...igned as a high throughput primary or backup instr...r offers performance and reliability equal to or g...advanced technology of the AUTION JET AJ-4270 and ...ate results, limiting interference from elevated p...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity
...rone Sulfate (E1S) is the most abundant circulatin... men [1,2]. Estrone Sulfate is a major metabolite ...fe in blood [2,3]. In premenopausal women, estrone...e and estradiol, rising gradually during the folli...
Medicine Products: